Terbinafine versus itraconazole: a long-term, randomized, double-blind, clinical trial in chronic pulmonary aspergillosis. A pilote study
Journal Title: Journal of Health and Social Sciences - Year 2016, Vol 1, Issue 1
Abstract
Background: The frequency of pulmonary aspergillosis has been increasing for decades. Standard oral treatment is associated with tolerability problems and interactions with commonly used medications. Present data suggest that terbinafine may be a useful alternative for chronic forms. Methods: A randomised, double-blind, multicentre trial compared terbinafine (500 mg b.i.d) with itraconazole (200 mg b.i.d.) with respect to successful outcomes for up to 6 months in 24 patients with chronic pulmonary aspergillosis. The primary end-point was a global clinical assessment using a 4-point rating scale, including (thorax) X-ray or Tc features. Secondary end-points were mycological response, duration of treatment and tolerability based on adverse events, haematology, biochemistry and urinalyses. Results: The patients were randomly allocated to terbinafine or itraconazole. No patients discontinued terbinafine, while 2 of 12 patients discontinued itraconazole because of protocol violation (n=1) or withdrawal of consent (n=1). The mean ± SD duration of the treatment was longer in the terbinafine group (139.8 ± 43.6 days vs 120.5 ± 41.8 days). The clinical success rate was also higher with terbinafine (91.7% vs 70.0%), as was the eradication rate (100% vs 75%). The proportion of patients who reported adverse events was higher with itraconazole (7 of 12 vs 3 of 12). Conclusions: Terbinafine (500 mg b.i.d. for up to 6 months) is an effective, well-tolerated antifungal agent for the treatment of chronic infectious forms of pulmonary aspergillosis, representing a valid alternative to treatment with itraconazole in these clinical forms, due to better clinical efficacy and safety and lower costs vs new azoles.
Authors and Affiliations
Gianfranco Schiraldi, Salvatore Lo Cicero, Claudio Rossetti, Delia Colombo, Michele Chiericozzi, Fabio Colombo, Maurizio Ferrarese, Elvana Kola, Luigi Allegra
Keywords
Related Articles
- EP ID EP216112
- DOI 10.19204/2016/trbn7
- Views 167
- Downloads 0
The migrant nightmare: Addressing disparities is a key challenge for developed nations
Editorial: The benefits of economic growth over the last 25 years have been unequally distributed. The gap between rich and poor is at its highest level in most Organisation for Economic Co-operation and Development (OEC...
Complications of tattoos and tattoos removal: state-of-the-art in Italy
Introduction: Modern tattoo removal began as a science approximately 20 years ago, and relatively few advances have been made since then. The aim of this study is twofold: first, to review the complications of tattoos an...
HIV risk perception and changes in sexual behavior and sexual satisfaction following male circumcision among circumcised males and their female partners from a traditionally noncircumcising community in Kenya, 2012-2014
Introduction: The aim of this study was to determine HIV risk perception, sexual satisfaction and condom use among recently-circumcised sexually-active males and their female partners from a traditionally noncircumcising...
Identifying barriers that prevent US insured adults at-risk for and diagnosed with type 2 diabetes from accessing primary care services: An exploratory study
Introduction: Type 2 diabetes is a condition that affects millions of individuals within the United States and it is one of the leading causes of death. Access to quality care is necessary to decrease the risk of develop...
Role and sensitivity of Positron Emission Tomography with [18F] Fluorodeoxyglucose in diagnosis and follow-up of patients affected by chronic pulmonary aspergillosis (CPA)
Introduction: PET/CT is considered as a powerful tool to diagnose, stage, and monitor patients with a variety of diseases. In this study, we assessed the sensitivity and the degree of agreement between 18F-FDG PET/CT and...